Showing results (1091-1100 of 1,171) with videos related to

Sort By:
Pageof 118
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]Zheng-gang Ren, Zhi-ying Lin, Jing-lin Xia, et al.
Gut|December 13, 2025
CD177+ neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regenerationJiayan Yan, Ao Huang, Shiyu Zhang, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
World Journal of Gastroenterology|April 6, 2019
International consensus statement on robotic hepatectomy surgery in 2018Rong Liu, Go Wakabayashi, Hong-Jin Kim, et al.
Hepatology (Baltimore, Md.)|May 23, 2015
Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transitionZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Gastroenterology|September 19, 2016
Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic AgentsQiang Gao, Zhi-Chao Wang, Meng Duan, et al.
Cell|October 5, 2019
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular CarcinomaQiang Gao, Hongwen Zhu, Liangqing Dong, et al.
Nature Communications|March 29, 2022
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinomaGuohe Song, Yang Shi, Lu Meng, et al.
BJS Open|September 20, 2022
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world studyWei-Feng Qu, Zhen-Bin Ding, Xu-Dong Qu, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Pageof 118